Analyst	Recommendation	Action	Price target	Projected	Date
Unknown Analyst Northland Securities	Hold	Maintained	$18.75	+177%	08/10/2026
Ryan MacDonald Needham	Buy	Reiterated	$30.00	+343.1%	08/07/2026
Ross Sandler Barclays	Hold	Reiterated	$3.00	-55.7%	05/08/2026
Bryan Smilek J.P. Morgan	Sell	Maintained	-	-	03/09/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	37.02M	49.11M	48.74M	43.23M
Cost of goods sold	13.72M	16.32M	16.46M	15.25M
Cost of revenue	13.72M	16.32M	16.46M	15.25M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	42.38M	38.94M	38.07M	33.58M
Operating expense	42.38M	38.94M	38.07M	33.58M
Total operating expenses	56.10M	55.26M	54.53M	48.82M
Operating income	-19.08M	-6.15M	-5.80M	-5.59M
Other non operating income	4.00K	2.00K	-16.00K	1.00K
EBT including unusual items	-18.72M	-14.02M	-6.11M	-6.82M
EBT excluding unusual items	-18.72M	-6.26M	-6.11M	-5.94M
Income tax expense	35.00K	22.00K	22.00K	34.00K
Effective tax rate	-0.19%	-0.16%	-0.36%	-0.50%
Other operating expenses	-	-	-	-
Net income	-12.29M	-9.24M	-4.08M	-4.65M
Net profit margin	-33.19%	-18.81%	-8.36%	-10.76%
Earnings per share	-1.47	-0.05	-0.02	-0.25
Interest and investment income	357.00K	-	368.00K	325.00K
Interest expense	-	-111.00K	-660.00K	-672.00K
Net interest expenses	357.00K	-111.00K	-292.00K	-347.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-18.79M	-5.86M	-5.50M	-5.32M
Gain or loss from assets sale	-	-	-	-

Ask anything